Intel (INTC) Q4 2025 earnings review
Solid Execution, But Margins Compress Again
Intel delivered a 'solid finish' to a volatile 2025 with Q4 revenue of $13.7B beating expectations. The long-awaited Intel 18A node has officially ramped to high-volume manufacturing—a critical operational milestone. However, the financial reality remains harsh. Supply constraints on legacy nodes and new product ramps are crushing profitability, with Q1 2026 guidance forecasting Adjusted Gross Margin compressing to 34.5% and EPS falling to $0.00. While the Data Center (DCAI) segment is finally accelerating (+9% YoY), the core Client business (CCG) is shrinking (-7% YoY), signaling that the AI PC cycle has yet to offset legacy weakness.
🐂 Bull Case
Intel 18A is no longer a concept; it has ramped to high-volume manufacturing in Arizona and Oregon. This is the lynchpin of the foundry strategy and product leadership. If yields hold, Intel's competitive footing changes materially in late 2026.
DCAI revenue accelerated to +9% YoY ($4.7B), proving that Intel is capturing some participation in the AI infrastructure build-out, likely driven by traditional compute head nodes.
🐻 Bear Case
Management warned that available supply will be at its 'lowest level in Q1' before improving. This inability to meet demand is capping revenue and forcing negative operational leverage.
Despite a 4% revenue bump, Intel Foundry posted a massive $2.5B operating loss in Q4. The unit remains a profound drag on consolidated earnings.
⚖️ Verdict: ⚪
Neutral. The operational turnaround (18A execution) is visible, but the financials are lagging. With EPS guiding to zero and margins dipping mid-30s, the transition pain is far from over.
Key Themes
Client Computing Weakness
Decelerating. Client Computing Group (CCG) revenue fell 7% YoY to $8.2B. Despite the 'AI PC' narrative, volumes or pricing are not compensating for legacy declines. This is a significant deviation from the Data Center recovery and suggests the PC refresh cycle is softer than anticipated.
18A High-Volume Manufacturing
Intel 18A is now in high-volume manufacturing (HVM). This is the 'make or break' node for the company's IDM 2.0 strategy. Achieving HVM signals that yield risks are moderating and products (like Panther Lake) are moving towards commercial availability. This validates the accelerated roadmap strategy.
Liquidity Injection
Intel completed the sale of $5.0 billion in common stock to NVIDIA and deconsolidated Altera (sold 51% stake in Q3). These moves have significantly fortified the balance sheet, providing a bridge through the capital-intensive 18A ramp without further dilutive equity raises or debt distress.
Foundry Losses Deepen
While Intel Foundry revenue grew 4% YoY to $4.5B, profitability remains elusive. The segment reported an operating loss of $2.5B in Q4, deteriorating from a $2.3B loss in Q3. The transition to EUV and new nodes is expensive, and external customer revenue has not yet scaled enough to cover fixed costs.
Supply Constraints Capping Upside
Management explicitly stated that available supply will be at its 'lowest level in Q1' before improving in Q2. This implies the company is leaving revenue on the table during a critical competitive window, likely due to tight capacity on legacy nodes (Intel 7) or packaging bottlenecks.
Altera Deconsolidation Impact
The 'All Other' segment revenue collapsed 48% YoY ($0.6B vs $1.1B) due to the Altera deconsolidation in Q3 2025. Investors must adjust models to account for this structural revenue hole moving forward; YoY comparisons for consolidated revenue are now distorted (-4% reported, but flat FY).
Other KPIs
Stable. Cash generation remains resilient despite P&L volatility. FY2025 OCF was $9.7B, covering a significant portion of the capital intensity, though net free cash flow remains pressured by CapEx.
Accelerating. Up 9% YoY and up ~13% sequentially (from $4.1B in Q3). This suggests Intel is successfully participating in the non-GPU portion of the AI buildout (head nodes, general compute).
Stable. The company is maintaining a steady non-GAAP tax rate, guiding to 11% for Q1 2026, which aids EPS visibility amidst operating line volatility.
Guidance
Decelerating. The midpoint ($12.2B) implies an 11% sequential decline from Q4 ($13.7B). Management attributes this to seasonal weakness exacerbated by supply shortages.
Reversing. After recovering to 40% in Q3 and 37.9% in Q4, margins are guiding back down toward the lows seen in Q2 2025. This indicates significant headwinds from product mix or ramp costs.
Decelerating. A stark drop from $0.15 in Q4. This reflects the 'negative operating leverage' caused by the revenue dip and margin compression.
Key Questions
Supply Constraint Specifics
You mentioned supply will be at its lowest level in Q1. Is this constraint primarily on legacy Intel 7 nodes or related to advanced packaging for new AI products? When specifically does supply catch up to demand?
Client Segment Weakness
CCG revenue dropped 7% YoY despite the AI PC narrative. Are you seeing share loss to ARM/AMD in the notebook segment, or is this purely a function of the supply constraints mentioned?
Foundry Margin Trajectory
With 18A entering high-volume manufacturing, when should we expect the Foundry segment to stop bleeding ~$2.5B per quarter? Does the HVM milestone trigger higher depreciation that might worsen losses in 2026?
18A External Customer Pipeline
Now that 18A is in HVM, have you secured any firm volume commitments from external customers beyond the previously announced partnerships? What is the timeline for the first meaningful external revenue on this node?
Gross Margin Bridge
Can you bridge the decline from 37.9% gross margin in Q4 to the 34.5% guidance for Q1? How much of this is structural mix shift versus temporary ramp costs?